The document discusses the epidemiology of AIDS, including:
- HIV originated from chimpanzees in central Africa and spread to humans in the early 20th century.
- AIDS is caused by HIV which attacks CD4 cells and leads to immunosuppression. There are 3 stages - asymptomatic, AIDS-related complex, and AIDS.
- India's HIV epidemic varies by state with some northeastern states having over 1% prevalence while southern states are lower. HIV transmission is mainly through unprotected sex and sharing of needles.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
HIV (Human Immunodeficiency Virus) infects cells of the immune system and destroys or impairs their function.
Infection progressive deterioration of the immune system breaking down the body's ability to fight out infections & diseases by opportunistic bacteria, viruses and fungi.
AIDS (Acquired Immune Deficiency Syndrome) refers to the most advanced stages of HIV infection and a collection of signs and symptoms caused by more than 20 opportunistic infections or related cancers.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
HIV (Human Immunodeficiency Virus) infects cells of the immune system and destroys or impairs their function.
Infection progressive deterioration of the immune system breaking down the body's ability to fight out infections & diseases by opportunistic bacteria, viruses and fungi.
AIDS (Acquired Immune Deficiency Syndrome) refers to the most advanced stages of HIV infection and a collection of signs and symptoms caused by more than 20 opportunistic infections or related cancers.
HIV AIDS Lecture Presented by me in my Community Dentistry Class, BIBI ASIFA DENTAL COLLEGE, SHAHEED MOHTARMA BENAZIR BHUTTO MEDICAL UNIVERSITY LARKANA, SINDH, PAKISTAN.
HIV AIDS Lecture Presented by me in my Community Dentistry Class, BIBI ASIFA DENTAL COLLEGE, SHAHEED MOHTARMA BENAZIR BHUTTO MEDICAL UNIVERSITY LARKANA, SINDH, PAKISTAN.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Home assignment II on Spectroscopy 2024 Answers.pdf
Epidemiology of AIDS
1. EPIDEMIOLOGY OF AIDS
Acquired Immune DeficiencyAcquired Immune Deficiency
SyndromeSyndrome
By
Dr. Anusha Divvi
Post graduate student
Department of Public Health
Dentistry
2. CONTENTS
• History
• Problem statement
• AIDS in world
• AIDS in India
• Epidemiological features
• Clinical manifestations
3. • Diagnosis of AIDS
• Control of AIDS
• Summary
• Conclusion
• References
4. What is HIV?
• H Human
• I Immunodeficiency
• V Virus
• It affects only humans and lives only in
humans
• Immunodeficiency refers to lack(deficiency)
or breakdown of immune system
5. What is AIDS?
• AIDS Acquired Immunodeficiency
Syndrome
• To acquire -- to develop over a period of time
• Immune system gets deficient
• Syndrome - group of signs and symptoms
that collectively indicate a disease
6. Where it came from??
• In 1999 - SIV (Simian Immunodeficiency
virus) - chimpanzee - almost identical to HIV
• Chimpanzees were the source of HIV-1 -
virus - from chimps to humans
• More research - how SIV could have
developed in the chimps
7. • Chimps had hunted and eaten 2 smaller species of
monkeys and became infected with 2 different strains
of SIV.
Greater spot-
nosed monkey Red-capped
mangabeys Chimp hunting
8. HOW DID VIRUS CROSS FROM CHIMPS TO
HUMANS?
• Simple and plausible theory - “Hunter Theory”
or “Bush Meat Theory”
• Blood of chimps getting into cuts or wounds on
the human hunter
9. DID HIV START IN AFRICA?
• Researchers concluded that the first
transmission of SIV to HIV in humans took
place around 1920 in Kinshasa in the
Democratic Republic of Congo, Central Africa.
10. How the virus came out of Kinshasa???
SEX TRADE
MIGRANTS
11. TIME - TRAVEL
• First reported case (1981)
• 1982 CDC coined “acquired
immunodeficiency syndrome” (AIDS)
• First isolation of LAV (1983)
– Luc Montagnier and colleagues -
African patient – lymphadenopathy
– LAV
12. • First isolation of HTLV (1984)
– Robert Gallo and colleagues
• First cases of HIV - India - 1986 - sex workers -
Chennai
• May 1986 - HIV
• National AIDS committee - 1986
• First AIDS case - 1987 in Mumbai.
• March 19, 1987 - Zidovudine - Food and Drug
Administration (FDA)
13. • 1st December - World AIDS Day - 1988
• Red ribbon - International symbol of AIDS
awareness – 1991
• NACO and NACP - 1992
• Triple-drug therapy - 1996 - world AIDS
conference in Vancouver
• David Ho - 1997 - a new treatment strategy
“Hit early, hit hard”
14. PROBLEM STATEMENT
• Global statistics (2015)
– 36.7 million [34.0 million–39.8 million]
people globally were living with HIV
– 2.1 million [1.8 million–2.4 million] people
became newly infected with HIV
– 1.1 million people died from AIDS-related
illnesses
– (http://www.unaids.org)
15. • 17 million people were accessing
antiretroviral therapy
• 78 million people have become infected with
HIV since the start of the epidemic
• 35 million people have died from AIDS-
related illnesses since the start of the epidemic
16. Indian statistics 2015
Estimated No. of people with
HIV
21,16,581
Adults 19,78,125
Children (<15) 1,38,456
Male 12,60,094
Female 8,56,487
Estimated AIDS prevalence
Total 0.26
Male 0.30
Female 0.22
17. Estimated No. of annual new
HIV infections
Total 86,309
Adults 75,948
Children (<15) 10,361
Estimated No. of AIDS related
deaths
Total 67,612
Adults 60,086
Children (<15) 7,526
18. Estimated ART need
Adults 12,70,678
Children (<15) 74,220
Estimated No. of mothers
needing PPTCT
Mothers needing PPTCT 35,255
19. OVERVIEW OF HIV IN INDIA
Prevalence of HIV in different states
• Manipur – 1.15%
• Mizoram – 0.80%
• Nagaland – 0.78%
• Andhra Pradesh – 0.66%
• Karnataka – 0.53%
• Tamilnadu – 0.28%
20. HIV EPIDEMICS
Who and UNAIDS defined 3 types of HIV
epidemics
• Low level HIV epidemics
• Concentrated HIV epidemics
• Generalized HIV epidemics
21. • Low level – prevalence has not consistently
exceeded 5% in any defined sub-population
• Concentrated – prevalence is consistently over
5% in at least one defined sub-population but is
below 1% in pregnant women
• Generalized – prevalence consistently over 1%
in pregnant women
22. EPIDEMIOLOGICAL FEATURES
1. AGENT
• Group: Lentivirus
• Subgroup: Retrovirus
• CD4+ T lymphocytes
• Macrophages and monocytes
• Slow infection with prolonged incubation
period.
23. Structure of the virus
• 120nm in diameter
• Envelope gp160; gp120 & gp41
• Icosahedral symmetry
• Nucelocapsid
• Outer matrix protein (p17)
• Major capsid protein (p24)
• Nuclear protein (p7)
• RNA with reverse transcriptase
24. RETRO VIRAL GENES
• gag (group-specific antigen): makes the
cone shape viral capsid
• pol (polymerase): codes for viral enzymes
reverse transcriptase, integrase, and viral
protease
• env (envelope): makes surface protein
gp120 and trans membrane gp41, enabling
HIV to fuse to CD4 cells.
25. RETRO VIRAL GENES
• Tat
The Trans
activator gene influences the function of
genes some distance away.
• Rav
The differential regulator of expression of
26. RETRO VIRAL GENES
• vif
• The virus infectivity factor gene required
for infectivity
• nef
• The negative regulator factor retards HIV
replication
• vpr
virus protein R - undetermined function
27. GENES IN HIV 1 AND HIV 2
• vpu
• Virus protein U gene is required for efficient
viral replication
• Found only in HIV-1
• vpx
• The virus protein X gene has an
undetermined function.
• It is found only in HIV-2
30. Reservoir of infection
• Cases and carriers.
• Once infected, the virus remains
in life-long
• Risk of developing AIDS
increases with time
• Symptomless carrier can infect
other people for years
31. SOURCE OF INFECTION
High concentration
• Blood
• Semen/Vaginal fluids
(as high as blood)
• Pus from sores
• CSF
Low concentration
• Sweat
• Tears
• Urine
• Saliva
• Breast milk
32. 2. HOST FACTORS
• Age: 20-49 years
• High risk groups: Male homosexuals, bisexuals,
intravenous drug abusers, transfusion
recipients of blood and blood products,
hemophiliacs
33. IMMUNOLOGY
• HIV selectively infects T-helper cells
• Healthy individual - twice as many helper
cells as suppressor cells
• It is reversed in AIDS
• striking feature - total lymphocyte count -
below 500 cu.mm.
• More prone for opportunistic infection,
neoplasm
34. MODE OF TRANSMISSION
• Sexual transmission
• Blood contact
• Maternal – foetal transmission
35. • Unprotected sex with multiple partners
• Sharing needles
• Pregnancy
• Breast feeding
• Blood transfusion
• Wound contacts
• Occupational exposure
36. INCUBATION PERIOD
• Current data suggest that the incubation period
is uncertain
• From a few months to 10 years or more
• Virus can lie silent in the body for many years
• Among the people infected with HIV- possibly
10-30 % - develop AIDS
37. • Another 25-30 % - AIDS-related complex.
• 75 per cent of those infected with HIV will
develop AIDS by the end of ten years
38. CLINICAL MANIFESTATIONS
1. Initial infection with the virus and
development of antibodies
2. Asymptomatic carrier state
3. AIDS – related complex
4. AIDS
39. INITIAL INFECTION
• Most HIV - infected people have no symptoms
for the first five years
• Look healthy and feel well
• Can transmit the virus to others.
• Once infected, people are infected for life
• HIV antibodies – 2 to 12 weeks – blood
stream
40. • Window period
• Period before the antibodies are produced
• Although the person is infectious he will test
negative on standard antibody blood test
41. ASYMPTOMATIC CARRIER STATE
• Infected people have antibodies
• No overt signs of disease
• Persistent generalized lymphadenopathy
42. AIDS RELATED COMPLEX
• Unexplained diarrhoea
• Fatigue
• Malaise
• Loss of more than 10% body weight
• Fever
• Night sweats and generalized
lymphadenopathy
• No opportunistic infections or cancers
43. AIDS
• End stage of HIV infection
• Tuberculosis and Kaposi sarcoma – seen early
• When T helper cells dropped to 100:
– Candida oesophagitis, Cryptococcus meningitis and
penicillosis
– Parasitic infections such as Pneumocystis carini
pneumonia or Toxoplasma gondii encephalitis
• AIDS encephalopathy dementia
47. QUESTIONS
• Target cells of HIV _________
• World’s AIDS day __________
• 3rd
clinical stage of HIV infection ______
• The genetic material of HIV _________
• GP 41 is ___________
49. EPIDEMIOLOGY OF AIDS
Acquired Immune DeficiencyAcquired Immune Deficiency
SyndromeSyndrome
By
Dr. Anusha Divvi
Post graduate student
Department of Public Health
Dentistry
50. • Diagnosis of AIDS
• Control of AIDS
• Summary
• Conclusion
• References
52. CLINICAL
1. WHO case definition for AIDS surveillance
• At least 2 major signs in combination with at
least 1 of the minor signs
• Not due to a condition unrelated to HIV
infection
53. • Major signs
– Weight loss > 10% of body weight
– Chronic diarrhoea
– Prolonged fever
• Minor signs
• Persistent cough
• Oropharyngeal candidiasis
• Generalized lymphadenopathy
54. • History of herpes zoster
• Generalized pruritic dermatitis
• Chronic progressive herpes simplex infection
HSV 1
57. Expanded WHO case definition for AIDS
surveillance
• For the purposes of AIDS surveillance
• If a test for HIV antibody gives a positive
result, and one or more of the following
conditions are present :
58. • > 10% body weight loss with diarrhoea or
fever or both
• Cryptococcal meningitis
• Pulmonary or extra-pulmonary tuberculosis
• Kaposi sarcoma
• Neurological impairment
• Candidiasis of oesphagus
• Invasive cervical cancer
59. CLINICAL STAGING
• WHO has developed a clinical staging system,
based on clinical criteria
• Clinical stage is important as a criterion for
starting antiretroviral therapy
62. • Clinical stage 3
• Unexplained severe weight loss
• Unexplained chronic diarrhoea for longer
than one month
• Unexplained persistent fever
• Persistent oral candidiasis
• Oral hairy leukoplakia
• Pulmonary tuberculosis
• Severe bacterial infections
63. Clinical stage 4
• HIV wasting syndrome
• Severe bacterial pneumonia
• Chronic herpes simplex infection
• Extra pulmonary tuberculosis
• Kaposi sarcoma
• HIV encephalopathy
• Invasive cervical carcinoma
64. Laboratory diagnosis of AIDS
• Immunological tests
• Specific tests
– Antigen detection
– Virus isolation
– Polymerase chain reaction
– Antibody detection
65. Immunological tests
• Lymphocyte count falls below 2000/cu mm
• T helper cell count will be less than 200/cu mm
• T4 : T8 cell ratio is reversed
• Thrombocytopenia
• Raised IgG levels
67. • P24 detection – ELISA
• Virus isolation – cultivation of patients
lymphocytes on uninfected lymphocytes
• Polymerase chain reaction:
– Gold standard for diagnosis
– Amplification of DNA segments for the detection of
pathogenic virus
• Antibody detection
– ELISA – screening
– Western blot - confirmatory
68. • To ensure accuracy two different tests
• First a sensitive test is used to detect the HIV-
antibodies
• second confirmatory test - any false positive
results.
70. • The confirmatory test is Western Blot -
detecting specific antibody to viral core protein
(p24) and envelop glycoprotein (gp41)
71. CONTROL OF HIV/AIDS
• There are four basic approaches to the control
of AIDS :
1. Prevention
2. Antiretroviral treatment
3. Specific prophylaxis
4. Primary health care
73. II. ANTIRETROVIRAL TREATMENT:
Advent of potent antiretroviral therapy -
1996 - revolution in the care of patients.
Treatments are not for cure
Meant for reduction of morbidity and
mortality
74. DRUGS USED FOR ART
• Nucleoside reverse transcriptase
inhibitors
–Lamivudine
–Stavudine
–Zidovudine
• Fusion inhibitors
–Enfuvirtide
78. HAART(Highly active antiretroviral therapy)
• Synergistic combinations of NRTIs and
Protease inhibitors
• Popular HAART combinations
• NRTIs(2)+PI(1)
• NRTI(1)+NNRTI(1)+PI(1)
• NRTI(1)+NNRTI(1)+PI(2)
79. III. SPECIFIC PROPHYLAXIS:
• Prophylaxis against M. tuberculosis is 300
mg Isoniazid daily for 9 months to 1 year
• Kaposi's sarcoma might be treated with
interferon or chemotherapy
•Antifungal drugs for candidiasis
80. IV. PRIMARY HEALTH CARE
Focus on five strategic directions:
1. Increasing knowledge of HIV serostatus
2. Accelerating HIV prevention
3. Accelerating the scale-up of HIV treatment
and care
4. Health systems strengthening
81. National AIDS control program
• It was launched in India in the year 1987.
• To implement and closely monitor the various
components of the programme
• Aim - to prevent further transmission of HIV to
decrease morbidity and mortality
82. • The Govt. of India initiated programmes of
prevention and raising awareness under:
»NACP-I (1992-99)
»NACP-II (1999-2006)
»NACP- III( 2006-2011)
83. • India has now developed the fourth National
Programme Implementation Plan (NACP-IV,
2012-2017).
• To halt and reverse - over the next 5 years by
integrating programmes for prevention, care,
support and treatment.
84. The services are :
1. Prevention services
2. Care support and treatment services
85. Preventive services
• Needle syringe exchange program
• Prevention and control of sexually transmitted
diseases
• Blood safety
• HIV counselling and testing services
• Prevention of parent to child transmission
• Condom promotion
86. Care support and treatment services
• Laboratory services for CD4 testing and other
investigations
• Free antiretroviral therapy
• Early infant diagnosis for HIV exposed infants
and children below 18 months
• HIV- TB coordination
• Treatment of opportunistic infections
87. Guidelines on HIV and infant feeding
• Till 2009, WHO advised HIV – positive
mothers to avoid breast feeding if they were
able to afford and store formula milk safely
• On 30th
November 2009, WHO released new
recommendations on infant feeding by HIV
positive mothers
88. • HIV positive mothers or their infants take
antiretroviral drugs throughout the period of
breast feeding and until the infant is 12 months
old
• Child can benefit from breast feeding with very
little risk of becoming infected with HIV
89. Nutrition requirements for people living with
HIV/AIDS
• Energy requirements – increase by 10% -
asymptomatic HIV infected adults and children
• 20 -30 % - symptomatic HIV and AIDS
• HIV infected 6-59 month old children –
Vitamin A supplements – 1 lakh IU – every 4-6
months
90. HIV SURVEILLANCE :
• To detect the spread of the disease
• To make appropriate strategy for prevention
and control
• Types of surveillance :
• HIV sero surveillance
• HIV sentinel surveillance
• AIDS case surveillance
• STD surveillance
91. Counselling and HIV testing services
1. Integrated counselling and testing
centres(ICTC)
2.Prevention of parents to child transmission
of HIV ( PPTCT)
3. HIV/ tuberculosis collaborative activities.
92. I. Integrated counselling and testing
centres(ICTC):
A) Fixed facility ICTCs:
i.Standalone ICTC( SA-ICTC)
ii.Facility integrated counselling and
testing centres( F-ICTC)
B) Mobile ICTC:
93. 2. Prevention of parents to child transmission of
HIV ( PPTCT)
Started in 2002
Now 15000 ICTCs offer PPTCT services to
pregnant women
Single dose of Nevirapine to multi-drug ARV
prophylaxis from 2012
94. • Andhra Pradesh, Karnataka and Tamil Nadu.
• From May 2013 national wide implementation
has done
95. 3. HIV/ tuberculosis collaborative activities
The risk of TB infection in HIV positive persons
increases manifolds.
NACO - with RNTCP - promoting cross referrals
for early diagnosis and treatment of
tuberculosis
96. NATIONAL AIDS TELEPHONE HELPLINE :
• A toll free national AIDS telephone helpline has
been set up to provide access to information
and counselling, on HIV/AIDS related issues.
• This is a computerized 4 digit number 1097,
with a voice response system linked with a
telephone helpline
97. HIV VACCINE
• Developing a safe, effective and affordable
vaccine to prevent HIV infection is the best
hope for controlling HIV epidemic
• In 2015 NIAID and collaborators launched
HVTN 100, an early stage clinical trial in South
Africa
• Designed to determine whether the regimen is
safe, tolerable and effective
99. CONCLUSION
• AIDS has rapidly established itself throughout
the world.
• Still a major health problem and lot needs to be
done to ensure the sustainability of these
programs
• Evolve mechanisms to ensure that HIV care is
provided along with general health care.
100. REFERENCES
1. Park.K. A textbook of Preventive and Social
Medicine.23rd
edition. Jabalpur. M/s
Banarsidas Bhanot Publishers:2014
2. Current Medical Diagnosis and Treatment
edited by Lawrence M. Tierncy, Jr Siephen J.
McPhee and Maxine A. Papadakis,
43rdEd.2004
101. 3. WHO 2004: Scaling up antiretroviral therapy
in resource-limited settings: treatment
guidelines for a public health approach; 27-47
4. WHO. 2008. Operations Manual for Delivery of
HIV Prevention, Care and Treatment at
Primary Health Centres in High-Prevalence
5. WHO Technical Consultation on Nutrient
Requirements for People Living with
HIV/AIDS (2003 : Geneva, Switzerland)
102. 6. Nutrient requirements for people living with
HIV/AIDS: report of a technical consultation,
World Health Organization, Geneva, 13-15
May 2003.
7. Coors M et al. Acute phase response and
energy balance in stable human
immunodeficiency virus- infected patients: a
doubly labelled water study. Journal of
Laboratory and Clinical Medicine, 2001,
138:94-100.
103. 8.Govt. of India (2011), Strategy and
Implementation Plan. National AIDS
Control Programme Phase IV (2012-2017),
NACO. Ministry of Health and Family
Welfare, New Delhi.
9. http://www.unaids.org
10. http://www.naco.gov.in
11. http://www.who.int